Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000988433 | SCV001138149 | pathogenic | Autoimmune lymphoproliferative syndrome type 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
NIHR Bioresource Rare Diseases, |
RCV001027571 | SCV001190141 | pathogenic | Inherited Immunodeficiency Diseases | 2019-01-01 | criteria provided, single submitter | research | |
Genomics Facility, |
RCV000988433 | SCV002073912 | likely pathogenic | Autoimmune lymphoproliferative syndrome type 1 | 2022-01-11 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252283 | SCV002523886 | likely pathogenic | See cases | 2020-11-12 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PS3, PS4, PM2 |
Ce |
RCV002275198 | SCV002563028 | pathogenic | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000988433 | SCV003439552 | pathogenic | Autoimmune lymphoproliferative syndrome type 1 | 2022-09-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg250*) in the FAS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 86 amino acid(s) of the FAS protein. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 802620). This variant is also known as p.R348X. This premature translational stop signal has been observed in individual(s) with autoimmune lymphoproliferative syndrome and/or clinical features of FAS-related conditions (PMID: 18948840, 21490157, 32499645). This variant is not present in population databases (gnomAD no frequency). |